122 related articles for article (PubMed ID: 28844157)
1. Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients.
Schack LMH; Petersen SE; Nielsen S; Lundby L; Høyer M; Bentzen L; Overgaard J; Andreassen CN; Alsner J
Acta Oncol; 2017 Nov; 56(11):1514-1521. PubMed ID: 28844157
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a scoring system for late anorectal side-effects in patients treated with radiotherapy for prostate cancer.
Petersen SE; Bentzen L; Emmertsen KJ; Laurberg S; Lundby L; Høyer M
Radiother Oncol; 2014 Apr; 111(1):94-9. PubMed ID: 24630536
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of late anorectal dysfunction following external beam radiotherapy for prostate cancer.
Petersen SE; Bregendahl S; Langschwager M; Laurberg S; Brock C; Drewes AM; Krogh K; Høyer M; Lundby L
Acta Oncol; 2014 Oct; 53(10):1398-404. PubMed ID: 24960583
[TBL] [Abstract][Full Text] [Related]
4. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.
Andreassen CN; Rosenstein BS; Kerns SL; Ostrer H; De Ruysscher D; Cesaretti JA; Barnett GC; Dunning AM; Dorling L; West CML; Burnet NG; Elliott R; Coles C; Hall E; Fachal L; Vega A; Gómez-Caamaño A; Talbot CJ; Symonds RP; De Ruyck K; Thierens H; Ost P; Chang-Claude J; Seibold P; Popanda O; Overgaard M; Dearnaley D; Sydes MR; Azria D; Koch CA; Parliament M; Blackshaw M; Sia M; Fuentes-Raspall MJ; Ramon Y Cajal T; Barnadas A; Vesprini D; Gutiérrez-Enríquez S; Mollà M; Díez O; Yarnold JR; Overgaard J; Bentzen SM; Alsner J;
Radiother Oncol; 2016 Dec; 121(3):431-439. PubMed ID: 27443449
[TBL] [Abstract][Full Text] [Related]
5. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
Barnett GC; Coles CE; Elliott RM; Baynes C; Luccarini C; Conroy D; Wilkinson JS; Tyrer J; Misra V; Platte R; Gulliford SL; Sydes MR; Hall E; Bentzen SM; Dearnaley DP; Burnet NG; Pharoah PD; Dunning AM; West CM
Lancet Oncol; 2012 Jan; 13(1):65-77. PubMed ID: 22169268
[TBL] [Abstract][Full Text] [Related]
6. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer.
Burri RJ; Stock RG; Cesaretti JA; Atencio DP; Peters S; Peters CA; Fan G; Stone NN; Ostrer H; Rosenstein BS
Radiat Res; 2008 Jul; 170(1):49-59. PubMed ID: 18582155
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.
Kerns SL; Ostrer H; Stock R; Li W; Moore J; Pearlman A; Campbell C; Shao Y; Stone N; Kusnetz L; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1292-300. PubMed ID: 20932654
[TBL] [Abstract][Full Text] [Related]
8. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature.
Budäus L; Bolla M; Bossi A; Cozzarini C; Crook J; Widmark A; Wiegel T
Eur Urol; 2012 Jan; 61(1):112-27. PubMed ID: 22001105
[TBL] [Abstract][Full Text] [Related]
9. Early hematologic changes during prostate cancer radiotherapy predictive for late urinary and bowel toxicity.
Pinkawa M; Ribbing C; Djukic V; Klotz J; Holy R; Eble MJ
Strahlenther Onkol; 2015 Oct; 191(10):771-7. PubMed ID: 26009493
[TBL] [Abstract][Full Text] [Related]
10. Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus.
Kalakota K; Liauw SL
Urology; 2013 Jun; 81(6):1196-201. PubMed ID: 23540863
[TBL] [Abstract][Full Text] [Related]
11. Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy.
Meyer F; Fortin A; Wang CS; Liu G; Bairati I
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1454-62. PubMed ID: 21640495
[TBL] [Abstract][Full Text] [Related]
12. Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer.
Thor M; Olsson CE; Oh JH; Petersen SE; Alsadius D; Bentzen L; Pettersson N; Muren LP; Waldenström AC; Høyer M; Steineck G; Deasy JO
Acta Oncol; 2015; 54(9):1326-34. PubMed ID: 26340136
[TBL] [Abstract][Full Text] [Related]
13. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
Kerns SL; Stock R; Stone N; Buckstein M; Shao Y; Campbell C; Rath L; De Ruysscher D; Lammering G; Hixson R; Cesaretti J; Terk M; Ostrer H; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e21-8. PubMed ID: 23021708
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
Kerns SL; Dorling L; Fachal L; Bentzen S; Pharoah PD; Barnes DR; Gómez-Caamaño A; Carballo AM; Dearnaley DP; Peleteiro P; Gulliford SL; Hall E; Michailidou K; Carracedo Á; Sia M; Stock R; Stone NN; Sydes MR; Tyrer JP; Ahmed S; Parliament M; Ostrer H; Rosenstein BS; Vega A; Burnet NG; Dunning AM; Barnett GC; West CM;
EBioMedicine; 2016 Aug; 10():150-63. PubMed ID: 27515689
[TBL] [Abstract][Full Text] [Related]
15. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
16. GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis.
Margalit DN; Jordahl KM; Werner L; Wang X; Gwo-Shu Lee M; Penney KL; Batista JL; Martin NE; Chan JM; Kantoff PW; Stampfer MJ; Nguyen PL; Mucci LA
Clin Genitourin Cancer; 2015 Aug; 13(4):370-377.e1. PubMed ID: 25662905
[TBL] [Abstract][Full Text] [Related]
17. Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFβ1 gene.
De Langhe S; De Ruyck K; Ost P; Fonteyne V; Werbrouck J; De Meerleer G; De Neve W; Thierens H
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):393-9. PubMed ID: 22658438
[TBL] [Abstract][Full Text] [Related]
18. Prediction of radiation-induced toxicity by in vitro radiosensitivity of lymphocytes in prostate cancer patients.
Pinkawa M; Brzozowska K; Kriehuber R; Eble MJ; Schmitz S
Future Oncol; 2016 Mar; 12(5):617-24. PubMed ID: 26806671
[TBL] [Abstract][Full Text] [Related]
19. Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy.
Feigenberg SJ; Hanlon AL; Horwitz EM; Uzzo RG; Eisenberg D; Pollack A
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):397-405. PubMed ID: 15890581
[TBL] [Abstract][Full Text] [Related]
20. Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes.
Oh JH; Kerns S; Ostrer H; Powell SN; Rosenstein B; Deasy JO
Sci Rep; 2017 Feb; 7():43381. PubMed ID: 28233873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
